Nissay Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,094
| Closed | -$854K | – | 766 |
|
|
2024
Q1 | $854K | Buy |
7,094
+101
| +1% | +$12.2K | 0.01% | 669 |
|
|
2023
Q4 | $860K | Sell |
6,993
-117
| -2% | -$14.4K | 0.01% | 648 |
|
|
2023
Q3 | $920K | Buy |
7,110
+288
| +4% | +$37.3K | 0.01% | 624 |
|
|
2023
Q2 | $846K | Sell |
6,822
-70
| -1% | -$8.68K | 0.01% | 645 |
|
|
2023
Q1 | $1.01M | Sell |
6,892
-254
| -4% | -$37.2K | 0.01% | 600 |
|
|
2022
Q4 | $1.14M | Sell |
7,146
-267
| -4% | -$42.5K | 0.01% | 566 |
|
|
2022
Q3 | $988K | Buy |
7,413
+343
| +5% | +$45.7K | 0.01% | 594 |
|
|
2022
Q2 | $1.1M | Sell |
7,070
-229
| -3% | -$35.7K | 0.01% | 571 |
|
|
2022
Q1 | $1.14M | Buy |
7,299
+170
| +2% | +$26.5K | 0.01% | 586 |
|
|
2021
Q4 | $908K | Buy |
7,129
+540
| +8% | +$68.8K | 0.01% | 658 |
|
|
2021
Q3 | $858K | Buy |
6,589
+245
| +4% | +$31.9K | 0.01% | 652 |
|
|
2021
Q2 | $1.13M | Buy |
6,344
+154
| +2% | +$27.4K | 0.01% | 608 |
|
|
2021
Q1 | $1.02M | Sell |
6,190
-84
| -1% | -$13.8K | 0.01% | 603 |
|
|
2020
Q4 | $1.04M | Sell |
6,274
-163
| -3% | -$26.9K | 0.02% | 579 |
|
|
2020
Q3 | $918K | Buy |
6,437
+111
| +2% | +$15.8K | 0.02% | 557 |
|
|
2020
Q2 | $698K | Buy |
6,326
+592
| +10% | +$65.3K | 0.01% | 609 |
|
|
2020
Q1 | $572K | Buy |
5,734
+121
| +2% | +$12.1K | 0.01% | 557 |
|
|
2019
Q4 | $838K | Buy |
+5,613
| New | +$838K | 0.02% | 569 |
|
|
2019
Q3 | – | Hold |
0
| – | -$763K | – | 585 |
|
|
2019
Q2 | – | Hold |
0
| – | -$791K | – | 567 |
|
|
2019
Q1 | – | Hold |
0
| – | -$662K | – | 548 |
|
|
2018
Q4 | – | Hold |
0
| – | -$852K | – | 544 |
|
|
2018
Q3 | – | Hold |
0
| – | -$848K | – | 526 |
|
|
2018
Q2 | – | Sell |
-4,860
| Closed | -$734K | – | 505 |
|
|
2018
Q1 | $734K | Buy |
4,860
+101
| +2% | +$15.3K | 0.02% | 530 |
|
|
2017
Q4 | $641K | Buy |
+4,759
| New | +$641K | 0.02% | 581 |
|